Condition

Covid-19 (2)

Sars-CoV2 (2)

Acute Respiratory Distress Syndrome (1)

Ards (1)

COVID (1)

Coronavirus (1)

Coronavirus Infection (1)

Severe Acute Respiratory Syndrome (1)

Severe Acute Respiratory Syndrome Coronavirus 2 (1)

Overall Status

Completed (1)

Recruiting (1)

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Apellis Pharmaceuticals, Inc. (1)

University Health Network, Toronto (1)

Collaborator

Michael Garron Hospital (1)

Intervention

apl-9 (1)

peginterferon lambda-1a (1)

placebo (1)

vehicle control (1)

Study Documents

Intervention Type

drug (2)

other (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

Sars-CoV2

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

COVID, Covid-19, Coronavirus Trial in Brazil, United States (APL-9, Vehicle Control)

Completed

Has Results

COVID
+8 more

APL-9
Vehicle Control

Fresno, California
+23 more

Mar 21, 2022

Sars-CoV2, Covid-19 Trial in Brazil, Canada (Peginterferon Lambda-1A, )

Recruiting

Sars-CoV2
Covid-19

Peginterferon Lambda-1A
placebo

Botucatu, Brazil
+6 more

Jan 17, 2022